Promotion of Hepatocellular Carcinoma by the Intestinal Microbiota and TLR4

Dapito, Dianne H., Mencin, Ali, Gwak, Geum-Youn, Pradere, Jean-Philippe, Jang, Myoung-Kuk, Mederacke, Ingmar, Caviglia, Jorge M., Khiabanian, Hossein, Adeyemi, Adebowale, Bataller, Ramon, Lefkowitch, Jay H., Bower, Maureen, Friedman, Richard, Sartor, R. Balfour, Rabadan, Raul, Schwabe, Robert F.·2012·Cancer Cell

DOI 10.1016/j.ccr.2012.02.007

Cited by (999)

Items 201–300 of 999

STK4 regulates TLR pathways and protects against chronic inflammation–related hepatocellular carcinoma
Weiyun Li, Jun Xiao, Xin Zhou, Ming Xu, Chaobo Hu, Xiaoyan Xu, Yao Lu, Chang Liu, Shengjie Xue, Lei Nie et al. · 2015 · Journal of Clinical Investigation
Targeting gut microbiota in hepatocellular carcinoma: probiotics as a novel therapy
Murphy Lam Yim Wan, Hani S El-Nezami · 2018 · HepatoBiliary Surgery and Nutrition
Targeting gut microbiota with dietary components on cancer: Effects and potential mechanisms of action
Jun Tao, Sha Li, Ren‐You Gan, Cai‐Ning Zhao, Xiao Meng, Hua‐Bin Li · 2019 · Critical Reviews in Food Science and Nutrition
Hepatocellular carcinoma: Mechanisms of progression and immunotherapy
Yu Jiang, Qiuju Han, Jian Zhang · 2019 · World Journal of Gastroenterology
Alterations of fecal bacterial communities in patients with lung cancer.
Weiquan Zhang, Shukang Zhao, Junwen Luo, Xiaopeng Dong, Yingtao Hao, Hui Li, Lei Shan, Yong Zhou, Hubo Shi, Zai-Yun Zhang et al. · 2018 · Europe PMC (PubMed Central)
Microbiota in cancer development and treatment
Muhammad Hassan Raza, Kamni Gul, Abida Arshad, Naveeda Riaz, Usman Waheed, Abdul Rauf, Fahad M. Aldakheel, Shatha Ahmed Alduraywish, Maqbool Ur Rehman, Muhammad Abdullah et al. · 2018 · Journal of Cancer Research and Clinical Oncology
Gut Microbiota in Intestinal and Liver Disease
Rheinallt M. Jones, Andrew Scott Neish · 2020 · Annual Review of Pathology Mechanisms of Disease
Proteomic and metabonomic biomarkers for hepatocellular carcinoma: a comprehensive review
Torben Kimhofer, Haddy K. S. Fye, Simon David Taylor-Robinson, Mark R. Thursz, Elaine C. Holmes · 2015 · British Journal of Cancer
Bile Acids and Cancer: Direct and Environmental-Dependent Effects
Agostino Di Ciaula, David Q.‐H. Wang, Emilio Molina‐Molina, Raquel Baccetto, Giuseppe Calamita, Vincenzo Ostilio Palmieri, Piero Portincasa · 2017 · Annals of Hepatology
The power of small changes: Comprehensive analyses of microbial dysbiosis in breast cancer
Sheetal Parida, Dipali Sharma · 2019 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
The Human Microbiota and Skin Cancer
Yu Ri Woo, Sang Hyun Cho, Jeong Deuk Lee, Hei Sung Kim · 2022 · International Journal of Molecular Sciences
Toll-like receptor 4: A potential therapeutic target for multiple human diseases
Wei, Jinrui, Zhang, Yan, Li, Haopeng, Wang, Fuquan, Yao, Shanglong · 2023 · Biomedicine & Pharmacotherapy
Hepatic stellate cells: balancing homeostasis, hepatoprotection and fibrogenesis in health and disease
Schwabe, Robert F., Brenner, David A. · 2025 · Nature Reviews Gastroenterology & Hepatology
The Liver at the Nexus of Host-Microbial Interactions
Andrew James Macpherson, Mathias F Heikenwälder, Stephanie Christine Ganal-Vonarburg · 2016 · Cell Host & Microbe
Gut-liver axis signaling in portal hypertension
Benedikt Simbrunner, Mattias Mandorfer, Michael Trauner, Thomas Reiberger · 2019 · World Journal of Gastroenterology
MyD88 in hepatic stellate cells enhances liver fibrosis via promoting macrophage M1 polarization
Jie Zhang, Yu Liu, Haiqiang Chen, Qi Yuan, Jinyan Wang, Meng Niu, Lingling Hou, Jianchun Gu, Jinhua Zhang · 2022 · Cell Death and Disease
Gut microbiota and liver disease
Amit Goel, Mahesh Chand Gupta, Rakesh Aggarwal · 2014 · Journal of Gastroenterology and Hepatology
Microbiota dysbiosis: a new piece in the understanding of the carcinogenesis puzzle
Valeria García-Castillo, Enrique Sanhueza, Eileen M. McNerney, Sergio A. Oñate, Apolinaria García · 2016 · Journal of Medical Microbiology
The Gut-liver Axis in Immune Remodeling: New insight into Liver Diseases
Xinyu Yang, Di Lu, Jianyong Zhuo, Zuyuan Lin, Modan Yang, Xiao Xu · 2020 · International Journal of Biological Sciences
Hepatic stellate cells control liver zonation, size and functions via R-spondin 3
Sugimoto, Atsushi, Saito, Yoshinobu, Wang, Guanxiong, Sun, Qiuyan, Yin, Chuan, Lee, Ki Hong, Geng, Yana, Rajbhandari, Presha, Hernandez, Celine, Steffani, Marcella et al. · 2025 · Nature
HMGB1 links chronic liver injury to progenitor responses and hepatocarcinogenesis
Hernandez, Celine, Huebener, Peter, Pradere, Jean-Philippe, Antoine, Daniel J., Friedman, Richard A., Schwabe, Robert F. · 2018 · Journal of Clinical Investigation
Gut microbiota and immunity relevance in eubiosis and dysbiosis
Hanan E. Al-Rashidi · 2021 · Saudi Journal of Biological Sciences
Intestinal Dysbiosis Amplifies Acetaminophen-Induced Acute Liver Injury
Schneider, Kai Markus, Elfers, Carsten, Ghallab, Ahmed, Schneider, Carolin Victoria, Galvez, Eric J.C., Mohs, Antje, Gui, Wenfang, Candels, Lena Susanna, Wirtz, Theresa Hildegard, Zuehlke, Sebastian et al. · 2021 · Cellular and Molecular Gastroenterology and Hepatology
Fusobacterium nucleatum promotes liver metastasis in colorectal cancer by regulating the hepatic immune niche and altering gut microbiota
Han Yin, Zhuangzhuang Miao, Lu Wang, Beibei Su, Chaofan Liu, Yu Tong Jin, Bili Wu, Hu Han, Xianglin Yuan · 2022 · Aging
The CCR2+ Macrophage Subset Promotes Pathogenic Angiogenesis for Tumor Vascularization in Fibrotic Livers
Matthias Bartneck, Peter L. Schrammen, Diana Möckel, Olivier Govaere, Anke Liepelt, Oliver Krenkel, Can Ergen, Misti Vanette McCain, Dirk Eulberg, Tom Luedde et al. · 2018 · Cellular and Molecular Gastroenterology and Hepatology
p53 haploinsufficiency and increased mTOR signalling define a subset of aggressive hepatocellular carcinoma
Yuandeng Luo, Lei Fang, Hongqiang Yu, Jie Zhang, Xiaotong Lin, Xiaoyu Liu, Di Wu, Gui-Xi Li, Huang Deng, Yujun Zhang et al. · 2020 · Journal of Hepatology
The gut microbiome-bile acid axis in hepatocarcinogenesis
Liwei Wu, Jiao Feng, Jingjing Li, Qiang Yu, Jie Ji, Jianye Wu, Weiqi Dai, Chuanyong Guo · 2020 · Biomedicine & Pharmacotherapy
Gut flora disequilibrium promotes the initiation of liver cancer by modulating tryptophan metabolism and up-regulating SREBP2
Wen Chen, Liang Wen, Yingying Bao, Zengwei Tang, Jianhui Zhao, Xiaozhen Zhang, Tao Wei, Jian Zhang, Tao Ma, Qi Zhang et al. · 2022 · Proceedings of the National Academy of Sciences
Intestinal dysbacteriosis-induced IL-25 promotes development of HCC via alternative activation of macrophages in tumor microenvironment
Li, Qiao, Ma, Lei, Shen, Shunli, Guo, Yu, Cao, Qinghua, Cai, Xiuqin, Feng, Juan, Yan, Yuan, Hu, Tianyu, Luo, Shiya et al. · 2019 · Journal of Experimental & Clinical Cancer Research
The Role of the Microbiome in Immunologic Development and its Implication For Pancreatic Cancer Immunotherapy
Vrishketan Sethi, Gerardo A. Vitiello, Deepak B. Saxena, George Miller, Vikas Dudeja · 2019 · Gastroenterology
Toll‐like receptors and liver disease
Varun Kesar, Joseph A. Odin · 2013 · Liver International
Gene network activity in cultivated primary hepatocytes is highly similar to diseased mammalian liver tissue
Patrício Godoy, Agata Widera, Wolfgang Schmidt‐Heck, Gisela Campos, Christoph Meyer, Cristina Cadenas, Raymond Reif, Regina M. Stöber, Seddik Hammad, Larissa Pütter et al. · 2016 · Archives of Toxicology
Cholesterol metabolism: physiological regulation and diseases
Jiarui Guo, Silong Chen, Ying Zhang, Jinxia Liu, Luyang Jiang, Lidan Hu, Ke Yao, Yibo Yu, Xiangjun Chen · 2024 · MedComm
Gut microbiome in metabolic dysfunction-associated steatotic liver disease and associated hepatocellular carcinoma
Harry Cheuk-Hay Lau, Xiang Zhang, Jun Yu · 2025 · Nature Reviews Gastroenterology & Hepatology
Butyrate production from high-fiber diet protects against lymphoma tumor
Wei, Wei, Sun, Wei, Yu, Shanshan, Yang, Yu, Ai, Limei · 2016 · Leukemia & Lymphoma
Application potential of toll-like receptors in cancer immunotherapy
Ming Shi, Xi Chen, Kangruo Ye, Yuanfei Yao, Li Yu · 2016 · Medicine
Gut–liver translocation of pathogen Klebsiella pneumoniae promotes hepatocellular carcinoma in mice
Xueliang Wang, Yi Fang, Wei Liang, Yuhong Cai, Chi Chun Wong, Junlin Wang, Na Wang, Harry Cheuk-Hay Lau, Ying Jiao, Xingyu Zhou et al. · 2025 · Nature Microbiology
Contributions of metabolic dysregulation and inflammation to nonalcoholic steatohepatitis, hepatic fibrosis, and cancer
Abigale G. Lade, Luke A. Noon, Scott L. Friedman · 2013 · Current Opinion in Oncology
Hepatic stellate cells: central modulators of hepatic carcinogenesis
Alexandra Thompson, Kylie P. Conroy, Neil Cowan Henderson · 2015 · BMC Gastroenterology
The Intratumoral Bacterial Metataxonomic Signature of Hepatocellular Carcinoma
Jian-Hang Huang, Jie Wang, Xiaoqiang Chai, Zhong-Chen Li, Ying-Hua Jiang, Jun Li, Xing Liu, Jia Fan, Jiabin Cai, Feng Liu · 2022 · Microbiology Spectrum
Antibiotic effects on gut microbiota, metabolism, and beyond
Chunlong Mu, Weiyun Zhu · 2019 · Applied Microbiology and Biotechnology
Liver Cancer Immunity
Sumera Irie Ilyas, Juan Wang, Anthony B. El‐Khoueiry · 2020 · Hepatology
FSTL1 Secreted by Activated Fibroblasts Promotes Hepatocellular Carcinoma Metastasis and Stemness
Jia-Jian Loh, Tsz-Wai Li, Lei Zhou, Tin Lok Wong, Xue Liu, Victor W.S. Ma, Chung-Mau Lo, Kwan Man, Terence K. Lee, Wen Ning et al. · 2021 · Cancer Research
Profiling of tumour-associated microbiota in human hepatocellular carcinoma
Komiyama, Seiga, Yamada, Takahiro, Takemura, Nobuyuki, Kokudo, Norihiro, Hase, Koji, Kawamura, Yuki I. · 2021 · Scientific Reports
Autophagy, the innate immune response and cancer
Chelsea Gerada, Kevin M. Ryan · 2020 · Molecular Oncology
Lipopolysaccharide-Induced Toll-Like Receptor 4 Signaling in Cancer Cells Promotes Cell Survival and Proliferation in Hepatocellular Carcinoma
Lili Wang, Rong Zhu, Zhiquan Huang, Haigang Li, Hongguang Zhu · 2013 · Digestive Diseases and Sciences
ACSL4-dependent ferroptosis does not represent a tumor-suppressive mechanism but ACSL4 rather promotes liver cancer progression
Julia Grube, Marius Maximilian Woitok, Antje Mohs, Stephanie Erschfeld, Celina Lynen, Christian Trautwein, Tobias Otto · 2022 · Cell Death and Disease
Current and emerging strategies for the prevention of hepatocellular carcinoma
Yee Hui Yeo, Manal F. Abdelmalek, Seema Ahsan Khan, Cynthia A. Moylan, Luz María Rodriquez, Augusto Villanueva, Ju Dong Yang · 2024 · Nature Reviews Gastroenterology & Hepatology
Dectin-1 Regulates Hepatic Fibrosis and Hepatocarcinogenesis by Suppressing TLR4 Signaling Pathways
Lena Seifert, Michael Deutsch, Sara Alothman, Dalia Alqunaibit, Gregor Werba, Mridul Pansari, Matthew Pergamo, Atsuo Ochi, Alejandro Torres-Hernandez, Elliot Levie et al. · 2015 · Cell Reports
Diet-induced gut dysbiosis and inflammation: Key drivers of obesity-driven NASH
Kang, Gideon G., Trevaskis, Natalie L., Murphy, Andrew J., Febbraio, Mark A. · 2023 · iScience
Systemic effects of gut microbiota and its relationship with disease and modulation
Jolie T.K. Ho, Gcf Chan, J. Li · 2015 · BMC Immunology
The microbiome and lung cancer
Abhiram Maddi, Amarpreet Sabharwal, Timothy Violante, Sunita Manuballa, Robert J. Genco, Santosh Kumar Patnaik, Sai Yendamuri · 2019 · Journal of Thoracic Disease
Gut microbiome interventions in human health and diseases
Pengqing Nie, Zhiqiang Li, Yimeng Wang, Yubing Zhang, Mengna Zhao, Jie Luo, Shiming Du, Zixin Deng, Jincao Chen, Yunfu Wang et al. · 2019 · Medicinal Research Reviews
Microbiota-driven mechanisms at different stages of cancer development
Elena Ivleva, Sergei I. Grivennikov · 2022 · Neoplasia
Pattern Recognition Receptors in Cancer Progression and Metastasis
Sanjay Pandey, Saurabh Pratap Singh, Vandana Anang, Anant Narayan Bhatt, Krishnamurthy Natarajan, Bilikere Srinivasa Rao Dwarakanath · 2015 · Cancer Growth and Metastasis
Diabetes and Colorectal Cancer Risk: Clinical and Therapeutic Implications
Guanhua Yu, Shuo-Feng Li, Ran Wei, Zheng Jiang · 2022 · Journal of Diabetes Research
Toll-like receptors and metabolic (dysfunction)-associated fatty liver disease
Shaghayegh Khanmohammadi, Mohammad Shafi Kuchay · 2022 · Pharmacological Research
An Immune Gene Expression Signature Associated With Development of Human Hepatocellular Carcinoma Identifies Mice That Respond to Chemopreventive Agents
Moeini, Agrin, Torrecilla, Sara, Tovar, Victoria, Montironi, Carla, Andreu-Oller, Carmen, Peix, Judit, Higuera, Mónica, Pfister, Dominik, Ramadori, Pierluigi, Pinyol, Roser et al. · 2019 · Gastroenterology
Unveiling the complex relationship between gut microbiota and liver cancer: opportunities for novel therapeutic interventions
Jayashi Rajapakse, Saroj Khatiwada, Anna Camille Akon, Kin Lam Yu, Sj Shen, Amany Zekry · 2023 · Gut Microbes
The Degree of Liver Injury Determines the Role of P21 in Liver Regeneration And Hepatocarcinogenesis in Mice
Laura Elisa Buitrago‐Molina, Silke Marhenke, Thomas Longerich, Amar Deep Sharma, Aristeidis E. Boukouris, Robert Geffers, Bruno Guigas, Michael Peter Manns, Arndt Vogel · 2013 · Hepatology
Carcinogenesis as a Result of Multiple Inflammatory and Oxidative Hits: a Comprehensive Review from Tumor Microenvironment to Gut Microbiota
Floriana Morgillo, Marcello Dallio, Carminia Maria Della Corte, Antonietta Gerarda Gravina, Giuseppe Viscardi, C. Loguercio, Fortunato Ciardiello, Alessandro Federico · 2018 · Neoplasia
Intestinal Microbial Variation May Predict Early Acute Rejection after Liver Transplantation in Rats
Zhigang Ren, Jianwen Jiang, Haifeng Lu, Xinhua Chen, Yong He, Hua Zhang, Haiyang Xie, Weilin Wang, Shusen Zheng, Lin Zhou · 2014 · Transplantation
Microbiota and gastrointestinal cancer
Meng‐Tzu Weng, Yu‐Tse Chiu, Ping‐Ya Wei, Chien-Wei Chiang, Huei‐Ling Fang, Shu‐Chen Wei · 2019 · Journal of the Formosan Medical Association
Circulating Microbiota-Based Metagenomic Signature for Detection of Hepatocellular Carcinoma
Eun Ju Cho, Sangseob Leem, Sun Ah Kim, Jinho Yang, Yun Bin Lee, Soon Sun Kim, Jae Youn Cheong, Sung Won Cho, Ji Won Kim, Sungmin Kim et al. · 2019 · Scientific Reports
Temporal Stability and the Effect of Transgenerational Transfer on Fecal Microbiota Structure in a Long Distance Migratory Bird
Jakub Kreisinger, Lucie Schmiedová, Adéla Petrželková, Marie Adámková, Oldřich Tomášek, Jean‐François Martin, Romana Michálková, Tomáš Albrecht · 2017 · Frontiers in Microbiology
Hepatic Stellate Cells and Liver Fibrosis
Puche, Juan E., Saiman, Yedidya, Friedman, Scott L. · 2013 · Comprehensive Physiology
lncRNA MALAT1 binds chromatin remodeling subunit BRG1 to epigenetically promote inflammation-related hepatocellular carcinoma progression
Mingyan Huang, Huamin Wang, Xiang Hu, Xuetao Cao · 2018 · OncoImmunology
Ileal FGF 15 contributes to fibrosis‐associated hepatocellular carcinoma development
Iker Uriarte, Maria Ujue Latasa, Simone Carotti, Maite G. Fernández‐Barrena, Oihane García‐Irigoyen, María Elizalde, Raquel Urtasun, Umberto Vespasiani Gentilucci, Sergio Morini, Álvaro de Mingo Pulido et al. · 2014 · International Journal of Cancer
Proteomics, Personalized Medicine and Cancer
Miao Su, Zhe Zhang, Li Zhou, Chao Han, Canhua Huang, Edouard Collins Nice · 2021 · Cancers
Genetic lineage tracing analysis of the cell of origin of hepatotoxin‐induced liver tumors in mice
Soona Shin, Kirk J. Wangensteen, Monica Teta‐Bissett, Yue Julia Wang, Elham Mosleh‐Shirazi, Elizabeth L. Buza, Linda E. Greenbaum, Klaus H. Kaestner · 2016 · Hepatology
Gut microbial dysbiosis associates hepatocellular carcinoma via the gut-liver axis
Jianwen Jiang, Xinhua Chen, Zhigang Ren, Shusen Zheng · 2018 · Hepatobiliary & pancreatic diseases international
The role of the gut microbiome in the development and progression of liver cirrhosis and hepatocellular carcinoma
Christoph Roderburg, Tom Luedde · 2014 · Gut Microbes
Oxidative stress and hepatic Nox proteins in chronic hepatitis C and hepatocellular carcinoma
Jinah Choi, Nicole Leanne Bidaud Corder, Bhargav Koduru, Yiyan Wang · 2014 · Free Radical Biology and Medicine
Toll-like receptor-induced cytokines as immunotherapeutic targets in cancers and autoimmune diseases
Mahesh Chandra Patra, Masaud Shah, Sangdun Choi · 2019 · Seminars in Cancer Biology
The zinc finger protein Miz1 suppresses liver tumorigenesis by restricting hepatocyte-driven macrophage activation and inflammation
Wenjie Zhang, Guangyan Zhangyuan, Fei Wang, Kangpeng Jin, Haiyuan Shen, Liansheng Zhang, Xiang Yuan, Jincheng Wang, Haitian Zhang, Weiwei Yu et al. · 2021 · Immunity
The Role of Gut Microbiota in Some Liver Diseases: From an Immunological Perspective
Li Wang, Zheng-Min Cao, Lili Zhang, Juan-Mei Li, Wenliang Lv · 2022 · Frontiers in Immunology
Gut Microbiota and Breast Cancer: The Dual Role of Microbes
Ana I. Álvarez‐Mercado, Ana del Valle Cano, Mariana Fátima Fernández, Luis Fontana · 2023 · Cancers
Gut-liver axis calibrates intestinal stem cell fitness
Girak Kim, Zuojia Chen, Jian Li, Jialie Luo, Felipe Castro-Martínez, Jan Wiśniewski, Kairong Cui, Yan Wang, Jialei Sun, Xiaobai Ren et al. · 2024 · Cell
An HNF4α–microRNA-194/192 signaling axis maintains hepatic cell function
Aoi Morimoto, Mana Kannari, Yuichi Tsuchida, Shota Sasaki, Chinatsu Saito, Tsuyoshi Matsuta, Tsukasa Maeda, Megumi Akiyama, Takahiro Nakamura, Masakiyo Sakaguchi et al. · 2017 · Journal of Biological Chemistry
Gut microbiota, fatty liver disease, and hepatocellular carcinoma
Chu, Huikuan, Williams, Brandon, Schnabl, Bernd · 2018 · Liver Research
Current perspectives on the tumor microenvironment in hepatocellular carcinoma
Cositha Santhakumar, Edward John Gane, Ken Liu, Geoffrey William McCaughan · 2020 · Hepatology International
Liver Inflammation and Hepatobiliary Cancers
Valentina Leone, Adnan Ali, Achim Weber, Darjus Felix Tschaharganeh, Mathias F Heikenwälder · 2021 · Trends in cancer
Role of lymphocytes in liver cancer
Jana C. Mossanen, Frank Tacke · 2013 · OncoImmunology
From MAFLD to hepatocellular carcinoma and everything in between
Sarah Da Won Bae, Jacob George, Liang Qiao · 2022 · Chinese Medical Journal
Intestinal barrier dysfunction in cirrhosis: Current concepts in pathophysiology and clinical implications
Georgios I. Tsiaoussis · 2015 · World Journal of Hepatology
TLR4 signaling promotes a COX-2/PGE2/STAT3 positive feedback loop in hepatocellular carcinoma (HCC) cells
Ang Lin, Guan Wang, Huajun Zhao, Yuyi Zhang, Qiuju Han, Cai Zhang, Zhigang Tian, Jian Zhang · 2015 · OncoImmunology
Applying ecological and evolutionary theory to cancer: a long and winding road
Frédéric Thomas A, Daniel Fisher, Philippe Fort, Jean‐Pierre Marie, Simon P. Daoust, Benjamín Roche, Christoph Grunau, Céline Cosseau, Guillaume Mitta, Stephen Baghdiguian et al. · 2012 · Evolutionary Applications
MicroRNA‐21 and Dicer are dispensable for hepatic stellate cell activation and the development of liver fibrosis
Jorge Matías Caviglia, Jun Yan, Myoung Kuk Jang, Geum‐Youn Gwak, Silvia Affò, Le‐Xing Yu, Peter Olinga, Richard A. Friedman, Xin Chen, Robert F. Schwabe · 2017 · Hepatology
Effects of the gut-liver axis on ischemia-mediated hepatocellular carcinoma recurrence in the mouse liver
Lorenzo A. Orci, Stéphanie Lacotte, Vaihere Delaune, Florence Slits, Graziano Oldani, Vladimir Lazarević, Carlo Rossetti, Laura Rubbia‐Brandt, Philippe Morel, Christian Toso · 2018 · Journal of Hepatology
Gut Microbiota Influence in Hematological Malignancies: From Genesis to Cure
Mireia Uribe‐Herranz, Nela Klein-González, Luis Gerardo Rodríguez‐Lobato, Manel Juan, Carlos Fernández de Larrea · 2021 · International Journal of Molecular Sciences
Pro-inflammation NF-κB signaling triggers a positive feedback via enhancing cholesterol accumulation in liver cancer cells
Mingyan He, Wenhui Zhang, Yinying Dong, Li‐Shun Wang, Tingting Fang, Wenqing Tang, Bei Lv, Guanglang Chen, Biwei Yang, Peixin Huang et al. · 2017 · Journal of Experimental & Clinical Cancer Research
NOD2 inhibits tumorigenesis and increases chemosensitivity of hepatocellular carcinoma by targeting AMPK pathway
Xiaomin Ma, Yumin Qiu, Yanlin Sun, Lihui Zhu, Yunxue Zhao, Tao Li, Yueke Lin, Dapeng Ma, Zhenzhi Qin, Caiyu Sun et al. · 2020 · Cell Death and Disease
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of hepatocellular carcinoma
Tim F. Greten, Ghassan K. Abou‐Alfa, Ann‐Lii Cheng, Austin G. Duffy, Anthony B. El-Khoueiry, Richard S. Finn, Peter R. Galle, Lipika Goyal, Aiwu Ruth He, Ahmed Omar Kaseb et al. · 2021 · Journal for ImmunoTherapy of Cancer
Translating an Understanding of the Pathogenesis of Hepatic Fibrosis to Novel Therapies
Don C. Rockey · 2013 · Clinical Gastroenterology and Hepatology
Hypoxia: The “Invisible Pusher” of Gut Microbiota
Ni Han, Zhiyuan Pan, Guangwei Liu, Ruifu Yang, Yujing Bi · 2021 · Frontiers in Microbiology
Longitudinal Analysis of the Intestinal Microbiota in Liver Transplantation
Karin Kato, Miki Nagao, Kentaro Miyamoto, Kentaro Oka, Motomichi Takahashi, Masaki Yamamoto, Yasufumi Matsumura, Toshimi Kaido, Shinji Üemoto, Satoshi Ichiyama · 2017 · Transplantation Direct
Influences of the Gut Microbiota on DNA Methylation and Histone Modification
Jianzhong Ye, Wenrui Wu, Yating Li, Lanjuan Li · 2017 · Digestive Diseases and Sciences
Interplay of host microbiota, genetic perturbations, and inflammation promotes local development of intestinal neoplasms in mice
Gerold Bongers, Michelle E. Pacer, Thais Herrero Geraldino, Lili Chen, Zhengxiang He, Daigo Hashimoto, Gláucia C. Furtado, Jordi Ochando, Kevin A. Kelley, José C. Clemente et al. · 2014 · The Journal of Experimental Medicine
Intrahepatic microbes govern liver immunity by programming NKT cells
Joshua Leinwand, Bidisha Paul, Ruonan Chen, Fangxi Xu, Maria A. Sierra, Madan Mohan Reddy Paluru, Sumant Nanduri, Carolina Alcantara Hirsch, Sorin A. A. Shadaloey, Fan Yang et al. · 2022 · Journal of Clinical Investigation
Diabetes and cancer, common threads and missing links
Fang Hua, Jiaojiao Yu, Zhuowei Hu · 2016 · Cancer Letters